omeprazole has been researched along with Esophageal Dysmotility in 12 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"Twenty-five patients with systemic sclerosis and severe gastro-oesophageal reflux disease were treated with 20-80 mg omeprazole daily for up to 5 years." | 9.07 | Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. ( Hage, E; Hendel, J; Hendel, L; Stentoft, P, 1992) |
"Twenty-five patients with systemic sclerosis and severe gastro-oesophageal reflux disease were treated with 20-80 mg omeprazole daily for up to 5 years." | 5.07 | Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. ( Hage, E; Hendel, J; Hendel, L; Stentoft, P, 1992) |
"Patients with grade II-III oesophagitis underwent ambulatory motility/pH monitoring (using a Konigsberg catheter with four pressure transducers at 5 cm intervals) and solid bolus scintigraphy before and after treatment with omeprazole 20 mg b." | 3.70 | The effect of healing oesophagitis on oesophageal motor function as determined by oesophageal scintigraphy and ambulatory oesophageal motility/pH monitoring. ( Collins, JS; Ferguson, WR; Love, AH; McDougall, NI; McFarland, RJ; Mooney, RB, 1998) |
"Gastroesophageal reflux was found in 13 of 20 patients (65%) who underwent pH studies, and endoscopy detected one patient with erosive esophagitis." | 2.67 | Chest pain associated with nutcracker esophagus: a preliminary study of the role of gastroesophageal reflux. ( Achem, SR; Burton, L; Kolts, BE; Richter, JE; Wears, R, 1993) |
"Noncardiac chest pain is a common but important clinical challenge with respect to diagnostic strategy as well as therapeutic intervention." | 2.39 | Pathophysiology and management of noncardiac chest pain. ( Joseph, AS; Minocha, A, 1995) |
"Prednisone was continued with a slow taper, and after 1 month ber dysphagia had resolved and her esophageal manometry was normal." | 2.39 | Reversible esophageal motility disorder in a patient with sarcoidosis. ( Criss, DG; Geissinger, BW; Sharkey, MF; Wu, WC, 1996) |
"Chest pain is a common cause for referral to emergency departments." | 1.42 | A jackhammer in the gullet: high amplitude oesophageal contractions as a cause of atypical chest pain. ( Anggiansah, A; Goel, R; Wilkinson, M; Wong, T, 2015) |
"Radical treatment of GERD allows the pulmonologist to perform correct respiratory treatment and to prevent the development chronic and life-threatening complications." | 1.32 | Outcome of laparoscopic Nissen-Rossetti fundoplication in children with gastroesophageal reflux disease and supraesophageal symptoms. ( Castagnetti, M; Gentilino, V; Jasonni, V; Martino, F; Mattioli, G; Montobbio, G; Pini Prato, A; Sacco, O, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (58.33) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goel, R | 1 |
Anggiansah, A | 1 |
Wong, T | 1 |
Wilkinson, M | 1 |
Achem, SR | 2 |
Borjesson, M | 1 |
Rolny, P | 1 |
Mannheimer, C | 1 |
Pilhall, M | 1 |
Mattioli, G | 1 |
Sacco, O | 1 |
Gentilino, V | 1 |
Martino, F | 1 |
Pini Prato, A | 1 |
Castagnetti, M | 1 |
Montobbio, G | 1 |
Jasonni, V | 1 |
Xu, JY | 1 |
Xie, XP | 1 |
Hou, XH | 1 |
Minocha, A | 1 |
Joseph, AS | 1 |
Kolts, BE | 1 |
Wears, R | 1 |
Burton, L | 1 |
Richter, JE | 1 |
Adamek, RJ | 1 |
Wegener, M | 1 |
Wienbeck, M | 1 |
Pulte, T | 1 |
Geissinger, BW | 1 |
Sharkey, MF | 1 |
Criss, DG | 1 |
Wu, WC | 1 |
Wetscher, GJ | 1 |
Profanter, C | 1 |
Gadenstätter, M | 1 |
Perdikis, G | 1 |
Glaser, K | 1 |
Hinder, RA | 1 |
McDougall, NI | 1 |
Mooney, RB | 1 |
Ferguson, WR | 1 |
Collins, JS | 1 |
McFarland, RJ | 1 |
Love, AH | 1 |
Hendel, L | 1 |
Hage, E | 1 |
Hendel, J | 1 |
Stentoft, P | 1 |
3 reviews available for omeprazole and Esophageal Dysmotility
Article | Year |
---|---|
Treatment of non-cardiac chest pain.
Topics: Anti-Ulcer Agents; Botulinum Toxins, Type A; Calcium Channel Blockers; Chest Pain; Diltiazem; Enzyme | 2008 |
Pathophysiology and management of noncardiac chest pain.
Topics: Arousal; Chest Pain; Diagnosis, Differential; Esophageal Motility Disorders; Esophagogastric Junctio | 1995 |
Reversible esophageal motility disorder in a patient with sarcoidosis.
Topics: Adult; Deglutition Disorders; Drug Therapy, Combination; Esophageal Motility Disorders; Esophagus; F | 1996 |
3 trials available for omeprazole and Esophageal Dysmotility
Article | Year |
---|---|
Nutcracker oesophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Antacids; Anti-Ulcer Agents | 2003 |
Chest pain associated with nutcracker esophagus: a preliminary study of the role of gastroesophageal reflux.
Topics: Adult; Aged; Chest Pain; Esophageal Motility Disorders; Esophagoscopy; Esophagus; Female; Gastric Ac | 1993 |
Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis.
Topics: Adult; Aged; Barrett Esophagus; Drug Administration Schedule; Esophageal Motility Disorders; Esophag | 1992 |
6 other studies available for omeprazole and Esophageal Dysmotility
Article | Year |
---|---|
A jackhammer in the gullet: high amplitude oesophageal contractions as a cause of atypical chest pain.
Topics: Anti-Ulcer Agents; Chest Pain; Esophageal Motility Disorders; Gastroesophageal Reflux; Humans; Male; | 2015 |
Outcome of laparoscopic Nissen-Rossetti fundoplication in children with gastroesophageal reflux disease and supraesophageal symptoms.
Topics: Adolescent; Anti-Ulcer Agents; Asthma; Child; Child, Preschool; Combined Modality Therapy; Domperido | 2004 |
[Role of esophageal motility abnormalities in severe reflux esophagitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Esophageal Moti | 2005 |
Esophageal motility disorders and their coexistence with pathologic acid reflux in patients with noncardiac chest pain.
Topics: Adult; Aged; Analysis of Variance; Anti-Ulcer Agents; Chest Pain; Diagnosis, Differential; Esophagea | 1995 |
Medical treatment of gastroesophageal reflux disease does not prevent the development of Barrett's metaplasia and poor esophageal body motility.
Topics: Anti-Ulcer Agents; Barrett Esophagus; Dose-Response Relationship, Drug; Esophageal Motility Disorder | 1997 |
The effect of healing oesophagitis on oesophageal motor function as determined by oesophageal scintigraphy and ambulatory oesophageal motility/pH monitoring.
Topics: Adult; Anti-Ulcer Agents; Esophageal Motility Disorders; Esophagitis; Esophagus; Female; Humans; Hyd | 1998 |